The latest update is out from Bioethics (BOTH).
Bioethics Ltd. is poised to acquire SILQ Technologies Corporation via a reverse triangular merger, aiming to own SILQ as a subsidiary and convert its shares into Bioethics stock. SILQ, known for its innovative chemical coatings, has FDA-cleared medical devices like a premium urinary catheter and plans to expand through a major contract with Vizient, Inc. While Bioethics stockholders may face significant dilution post-merger, with a 1-for-2 reverse stock split planned, the transaction is designed to be a tax-free reorganization, with the final terms still under negotiation and subject to numerous closing conditions.
Learn more about BOTH stock on TipRanks’ Stock Analysis page.